Keywords: 2-AG; 2-arachidonoylglycerol; ANOVA; analysis of variance; BLA; basolateral nucleus of amygdala; BSA; bovine serum albumin; CA1; dorsal field 1 of Ammon's horn; CA3; dorsal field 3 of Ammon's horn; CB1; cannabinoid receptor 1; CeA; central amygdaloid
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Stressor controllability; Ventromedial prefrontal cortex; Prelimbic; Endocannabinoids; Cannabinoid receptor; 2-AG; Depolarization induced suppression of inhibition;
Keywords: ADHD; Attention-deficit/hyperactivity disorder; BED; Binge-eating disorder; BOLD; Blood-oxygen-level dependent; BMI; Body mass index; BN; Bulimia nervosa; CNS; Central nervous system; DSM 5; Diagnostic and statistical manual of mental disorders, fifth edi
Keywords: Alcohol; Maternal separation; Adolescence; Endocannabinoids; Monoamines; Striatum; 2-AG; 2-arachidonoylglycerol; 2-LG; 2-linoleoylglycerol; 2-OG; 2-oleoylglycerol; 5-HIAA; 5-hydroxyindoleacetic acid; AEA; N-arachidonoylethanolamine; BAC; Blood Alcohol Con
Keywords: 2-AG; 2-arachidonoylglycerol; Aβ; β-amyloid; GABA; γ-amino butyric acid; AD; Alzheimer's diseases; ALS; amyotrophic lateral sclerosis; AEA; anandamide; EAE; autoimmune encephalomyelitis; BBB; blood brain barrier; CDB; cannabidiol; CB; cannabinoid rec
Keywords: Endocannabinoid; Synthesizing enzyme; 2-AG; Alcoholism; Stress;
Keywords: Bisphenol A; Pregnancy; Metabolomics; FAAH; Endocannabinoids; 2-AG; 2-arachidonoylglycerol; AMCAA; AMC Arachidonyl Amide; AEA; anandamide; BSTFA; N,O-bis(trimethylsilyl)trifluoroacetamide; eCB; endocannabinoids; FAA; fatty acid amide; FAAH; fatty acid ami
Keywords: 2-AG; 2-arachidonoylglycerol; β; standardized partial regression coefficient; FAAH; fatty acid amide hydrolase; FNT; fenitrothion; MNP; 3-methyl-4-nitrophenol; OP; organophosphate; R2; coefficient of determination adjusted for the degrees of freedom; sPL
Keywords: Ach; acetylcholine; 2-AG; 2-arachidonoylglycerol; Ang II; angiotensin II; AT1R; type 1 angiotensin receptor; BK; bradykinin; CB1R; type 1 cannabinoid receptor; DAG; diacylglycerol; DAGL; diacylglycerol lipase; EC; endocannabinoid; ERK; extracellular signa
Keywords: Cannabinoid Receptor type 2; Electrophysiology; Endocannabinoids; Somatosensory cortex; Slow self-inhibition; CB1R and CB2R; cannabinoid receptors type 1 and 2; SSI; slow self-inhibition; GIRK channel; G protein-coupled inward-rectifying K+ channel; GPCR;
Keywords: 2-AG; 2-arachidonoylglycerol; AD; atopic dermatitis; AEA; arachidonoylethanolamide; DAGL; diacylglycerol lipase; eCB; endocannabinoid; ECS; endocannabinoid system; EMT; endocannabinoid membrane transporter; FAAH; fatty acid amide hydrolase; LPS; lipopolys
Keywords: 2-AG; 2-arachidonoylglycerol; AADAC; arylacetamide deacetylase; ABHD5/CGI-58; alpha-beta-hydrolase domain containing 5/comparative gene identification-58; ATGL/ PNPLA2; adipose triglyceride lipase; CE; cholesteryl esters; CES/Ces; carboxylesterase; DG; di
Keywords: AADAC; arylacetamide deacetylase; AChE; acetylcholinesterase; AEA; arachidonoylethanolamide; 2-AG; 2-arachidonoylglycerol; BChE; butyrylcholinesterase; BBB; blood-brain barrier; CES1; carboxylesterases 1; CES2; carboxylesterases 2; CNS; central nervous sy
Keywords: Cannabinoids; Phytocannabinoids; Endocannabinoids; Therapeutic agents; AEA; Arachidonylethanolamine or Anandamide; 2-AG; 2-arachidonylglycerol; CB1; Cannabinoid receptor type 1; CB2; Cannabinoid receptor type 2; CBD; Cannabidiol; CBG; Cannabigerol; CBL; C
Keywords: 2-AG; 2-arachidonoyl glycerol; 11-nor-THC-COOH; 11-nor-tetrahydrocannabinol-9-caboxylic acid; 11-OH-THC; 11-hydroxy-tetrahydrocannabinol; 8-OH-THC; 8-hydroxy-tetrahydrocannabinol; CB; cannabinoid; CB1R; Type I cannabinoid receptor; CB2R; Type II cannabino
Keywords: Endocannabinoid; 2-AG; Anandamide; Peripheral; Western diet; Obesity;
Keywords: 2-AG; arachidonoylglycerol; AI; alkylindole; CB; cannabinoid; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; CSA4; combretastatin A4; DBT; delayed Brain Tumor; HA; hemagglutinin; LPA; lysophosphatidic acid; GBM; glioblastoma multiforme; SAR; st
Keywords: AEA; anandamide; 2-AG; 2-arachydonoylglycerol; DAGL; diacylglycerol lipases; ECS; endogenous cannabinoid system; FAAH; fatty acid amide hydrolase; MAGL; monoacylglycerol lipase; NAPE-PLD; N-acyl-phosphatidylethanolamine-selective phospholipase D; OEA; ole
Keywords: 2-AG; 2-Arachidonoylglycerol; ACN; Acetonitrile; AEA; Anandamide; cAMP; cyclic adenosine 5â²-monophosphate; CB1R; Cannabinoid Receptor 1; CB2R; Cannabinoid Receptor 2; CI; Cell Index; CNR1; Cannabinoid Receptor 1 gene; CNR2; Cannabinoid Receptor 2 gene;
Keywords: ABHD; α/β hydrolase domain containing protein; Î9-THC; Î9-tetrahydrocannabinol; 2-AG; 2-arachidonoyl glycerol; 2-OG; 2-oleoyl glycerol; DGAT; acyl-CoA:diacylglycerol acyltransferase; MGAT; acyl-CoA:monoacylglycerol acyltransferase; ATGL; adipose trigl
Keywords: Antinociception; CB2 cannabinoid receptor agonist; Inflammation; Morphine; Reward; Synergy; 2-AG; 2-arachidonoylglycerol; %MPE; percent maximal possible effect; A50; potency; a-CSF; artificial spinal fluid; CB1; cannabinoid 1 receptor; CB2; cannabinoid 2
Keywords: Alcohol; Endocannabinoids; Sex differences; Anxiety; Amygdala; Prefrontal cortex; 2-AG; 2-arachidonoylglycerol; AEA; anandamide; ANOVA; analyses of variance; BAL; blood alcohol level; BLA; basolateral amygdala; CB1R; cannabinoid-type 1 receptor; CIA; chro
Keywords: 2-AG; 2-arachidonoyl glycerol; BA; basal nucleus of the amygdala; eCBs; endocannabinoids; FAAH; fatty acid amide hydrolase; HFO; high frequency oscillations; KA; kainic acid; LFP; local field potential; MS; medial septum; SE; status epilepticus; AM404; UR
Keywords: 2-AG; 2-arachidonoyglycerol; AEA; arachidonoylethanolamide; AEs; acylethanolamides; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; DAGL; diacylglycerol lipase; eCBs; endocannabinoids; ECS; endogenous cannabinoid system; FAAH; fatty acid amide h
Keywords: AA; arachidonic acid (20:4n-6); ABHD; α,β-hydrolase; AC; acid ceramidase; AEA; N-arachidonoylethanolamide; 2-AG; 2-arachidonoylglycerol; AD; Alzheimer's disease; ALA; α-linolenic acid (18:3n-3); ASM; acid sphingomyelinase; AMPA; alpha-amino-3-hydroxy
Keywords: Homeostasis; Obesity; Pharmacotherapy; Reward; AgRP; agouti-related protein; α-MSH; alpha-melanocyte stimulating hormone; 2-AG; 2-arachidonoylglycerol; BDNF; brain derived neurotrophic factor; BOLD; blood-oxygen level dependent; CB1; cannabinoid-1; CB2;
Keywords: 2-AG; 2-araquinodonoylglycerol; AChE; acetylcholinesterase; aCSF; artificial cerebrospinal fluid; AD; Alzheimer's disease; AEA; anandamide; CNS; central nervous system; CPA; cyclic phosphatidic acid; GlcCer; glucosylceramide; GSL; glycosphingolipid; LacCe
Keywords: Obesity; Osteoporosis; Bone marrow fat; Inflammation; Fracture; 25OHD; 25-hydroxyvitamin D; 2-AG; 2-arachidonoylglycerol; AEA; N-arachidonoylethanolamine; BAT; brown adipose tissue; BMD; bone mineral density; BMAT; bone marrow adipose tissue; BMI; body ma
Keywords: 2-AG; 2-arachidonoylglycerol; 2-OG; 2-oleoylglycerol; AEA; arachidonylethanolamine/anandamide; BLA; basolateral amygdala; eCB; endocannabinoid; FAAH; fatty acid amide hydrolase; MGL; monoacylglycerol lipase; mPFC; medial prefrontal cortex; NAc; nucleus ac
Keywords: AC; adenyl cyclase; AD; Alzheimer's disease; 2-AG; 2-arachidonoylglycerol; ABHD6; α,β hydrolase 6; AEA; arachidonylethanolamide/anandamide; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; cAMP; cyclic adenosine monophosphate; CBD; cannabid
Keywords: Traumatic brain injury; Chronic traumatic encephalopathy; Tauopathy; Concussion; Repetitive head injury; 2-AG; 2-arachidonoylglycerol; 3-NT; 3-nitrotyrosine; 4-HNE; 4-hydroxynonenal; Ach; acetylcholine; AChEI; acetylcholine esterase inhibitor; AD; Alzheim
Keywords: Adipose tissue macrophages; Omega-3 PUFA; Protectin D1; Lipid mediators; Lipidomics; 2-AG; 2-arachidonoylglycerol; anandamide; N-arachi-donoylethanolamine; 17-HDHA; 17-hydroxy docosahexaenoic acid; ATMs; adipose tissue macrophages; CD11b; integrin αM cha
Keywords: 2-AG; 2-arachidonoylglycerol; ALK; anaplastic lymphoma kinase; ATF-4; activating transcription factor 4; CB1; cannabinoid CB1 receptor; CB2; cannabinoid CB2 receptor; CBD; cannabidiol; CHOP; C/EBP homologous protein; EGFR; epidermal growth factor receptor
Keywords: ECS; endogenous cannabinoid system; CB1 receptor; cannabinoid receptor type 1; TBI; traumatic brain injury; AEDs; antiepileptic drugs; eCBs; endocannabinoids; PTE; post-traumatic epilepsy; FPI; fluid percussion injury; AEA; anandamide; 2-AG; 2-arachidonoy
Keywords: Cannabinoid receptors; 2-AG; Cerebellum; Eyeblink conditioning; Consolidation;
Keywords: [3H]DG; [3H]-2-deoxy-d-glucose; [18F]FDG-PET; [18F]-fluorodeoxyglucose-positron emission tomography; [3H]GABA; tritiated γ-aminobutyric acid; 2-AG; 2-arachidonoyl-glycerol; 3Rs; replacement refinement and reduction of animals in research; α,βHD6/12; α
Keywords: Anandamide; 2-AG; Oleamide N-acylethanolamides; Cannabinoid system; Sleep-waking cycle;
Keywords: 2-AG; 2-arachidonoylglycerol; AA; arachidonic acid; ABHD4; α/β-hydrolase domain-containing protein 4; ABHD6; α/β-hydrolase domain-containing protein 6; ABHD12; α/β-hydrolase domain-containing protein 12; AEA; arachidonoylethanolamine; CB1; cannabino
Keywords: 2-AG; 2-arachidonyl glycerol; 20-HETE; 20-hydroxy-5,8,11,14-eicosatetraenoic acid; 9-HODE; 9-hydroxy-octadecadienoic; 13-HODE; 13-hydroxy-octadecadienoic; AA; arachidonic acid; AEA; anandamide; ALA; α-linolenic acid; BMI; body mass index (kg/m2); cAMP; c
Keywords: 2-AG; 2-arachidonoyl-glycerol; AEA; anandamide; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; DOPAC; 3,4-Dihydroxyphenylacetic acid; DA; dopamine; D2; dopamine receptor subtype 2; ECS; endocannabinoid sys
Keywords: 2-AG; 2-arachidonoylglycerol; 5-HT; 5-hydroxytryptamine or serotonin; AEA; N-arachidonoylethanolamine or anandamide; cAMP; cyclic adenosine monophosphate; CB1R; cannabinoid receptor-1; DAPI; 4,6-diamidino-2-phenylindole; DR; dorsal root; FL; fictive locom
Keywords: ABHD12; α/β-hydrolase domain-containing 12; 2-AG; 2-arachidonoylglycerol; CNS; Central Nervous System; Ct; threshold cycle; DAGL; diacylglycerol lipase; FAAH; fatty acid amide hydrolase; [18F]FDG; 2-deoxy-2-[18F]fluoro-D-glucose; GLAST; glutamate-aspart
Keywords: AEA; N-arachidonoylethanolamine; 2-AG; 2-arachidonoylglycerol; ALT; alanine aminotransferase; ARA; arachidonic acid; CB1; cannabinoid receptor 1; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; LA; linoleic acid; LDH; lactate dehydrogenase; NAFLD;
Keywords: Tinnitus; Cannabinoids; Cannabinoid receptors; Delta-6-THC; Cannabidiol (CBD); Delta-9-THC; Delta-9-tetrahydrocannabinol; 2-AG; 2-arachidonylglycerol; DAG; diacylglycerol lipase; CN; cochlear nucleus; DCN; dorsal cochlear nucleus; VCN; ventral cochlear nu
Keywords: WKY; Wistar Kyoto; SD; Sprague-Dawley; qRT-PCR; quantitative real time polymerase chain reaction; AEA; anandamide; 2-AG; 2-arachidonoylglycerol; MAGL; monoacylglycerol lipase; FAAH; fatty acid amide hydrolase; CB1; cannabinoid receptor 1; SIH; stress-in
Keywords: 2-AG; 2-arachidonyl glycerol; AEA; anandamide; CB; cannabinoid receptor; CBD; cannabidiol; COX-2; cyclooxygenase 2; ERK1/2; extracellular signal-regulated kinase ½; FAAH; fatty acid amide hydrolase; IFN; interferon; IL; interleukin; iNOS; inducible nitri
Keywords: Phospholipid asymmetry; Lysophosphatidic; Platelet-activating factor; Phosphoinositides; PLRP2; Phospholipase B; 2-AG; 2-arachidonoyl-glycerol; ATX; autotaxin; cPLA2; cytosoluble phospholipase A2; DAG; diacylglycerol; ECs; endocannabinoids; IP3; inositol
Keywords: BDL; bile duct ligation; CB1; Cannabinoid receptor-1; GdCl3; gadolinium chloride; AEA; anandamide; 2-AG; 2-arachidonoyl glycerol; ESPVR; end-systolic pressure-volume relationship; Cirrhosis; Cardiomyopathy; Endocannabinoids; AM251; Hemorrhage; CB-1; Monoc
Keywords: Depressive symptoms; Psychosocial factors; Endocannabinoids; 2-AG; Pro-inflammatory molecules
Keywords: NAFLD; non-alcoholic fatty liver disease; NMR; nuclear magnetic resonance; THCV; Î9-tetrahydrocannabivarin; CBD; cannabidiol; AEA; anandamide; 2-AG; 2-arachidonoylglycerol; CB1/2; Cannabinoid receptor 1/2; THC; Î9-tetra-hydrocannabinol; HHL-5; human hep